A phase 3 study of biosimilar BI 695501 versus adalimumab in patients with Crohn’s disease - VJBM

Поділитися
Вставка
  • Опубліковано 27 вер 2024
  • In this video, Professor Stephen Hanauer presents the results from the phase III VOLTAIRE-CD study: comparing the safety and efficacy of BI 695501 versus adalimumab in patients with Crohn’s disease.
    Subscribe: www.youtube.co...
    Visit The Video Journal of Biomedicine: www.biomedicin...
    Follow us on Twitter: / vjofbiomedicine
    LinkedIn: / video-journal-of-biome...
    Facebook: / videojournalbiomedicine

КОМЕНТАРІ •